Researchers seek FDA transparency on use of surrogate endpoints outside of oncology
In a study published Monday in JAMA, researchers are calling on the FDA to share more about how the agency considers the use of surrogate …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
